MeiraGTx (MGTX) Competitors

Amneal Pharmaceuticals (NASDAQ:AMRX) and MeiraGTx (NASDAQ:MGTX) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations.

Do institutionals & insiders have more ownership in AMRX or MGTX?

31.8% of Amneal Pharmaceuticals shares are owned by institutional investors. Comparatively, 67.5% of MeiraGTx shares are owned by institutional investors. 26.6% of Amneal Pharmaceuticals shares are owned by insiders. Comparatively, 7.5% of MeiraGTx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Do analysts recommend AMRX or MGTX?

Amneal Pharmaceuticals currently has a consensus target price of $11.60, suggesting a potential upside of 22.75%. MeiraGTx has a consensus target price of $24.00, suggesting a potential upside of 193.76%. Given MeiraGTx's higher possible upside, analysts clearly believe MeiraGTx is more favorable than Amneal Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amneal Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
MeiraGTx	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is AMRX or MGTX more profitable?

Amneal Pharmaceuticals has a net margin of 0.12% compared to MeiraGTx's net margin of -415.39%. Amneal Pharmaceuticals' return on equity of -189.49% beat MeiraGTx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amneal Pharmaceuticals	0.12%	-189.49%	6.17%
MeiraGTx	-415.39%	-239.38%	-59.35%

Which has better earnings & valuation, AMRX or MGTX?

Amneal Pharmaceuticals has higher revenue and earnings than MeiraGTx. MeiraGTx is trading at a lower price-to-earnings ratio than Amneal Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amneal Pharmaceuticals	$2.85B	1.04	-$116.89M	$0.01	945.00
MeiraGTx	$34.51M	19.03	-$147.79M	-$2.04	-4.00

Does the media refer more to AMRX or MGTX?

In the previous week, Amneal Pharmaceuticals had 9 more articles in the media than MeiraGTx. MarketBeat recorded 17 mentions for Amneal Pharmaceuticals and 8 mentions for MeiraGTx. MeiraGTx's average media sentiment score of 0.56 beat Amneal Pharmaceuticals' score of 0.47 indicating that MeiraGTx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amneal Pharmaceuticals	6 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
MeiraGTx	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, AMRX or MGTX?

Amneal Pharmaceuticals has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Comparatively, MeiraGTx has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500.

Summary

Amneal Pharmaceuticals beats MeiraGTx on 10 of the 15 factors compared between the two stocks.